The gluten-specific enzyme ALV003 reduces a patient's exposure to gluten and its potential harm, according to a new phase 2 study. This study is the first to find that a non-dietary intervention can potentially benefit celiac disease patients.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/_...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/_...